Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 41.44
+0.41 (1.00%)
At close: Dec 5, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €184.19 billion as of December 5, 2025. Its market cap has decreased by -57.15% in one year.
Market Cap
184.19B
Enterprise Value
193.38B
Revenue
42.26B
Ranking
n/a
PE Ratio
13.26
Stock Price
€41.44
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 184.19B, an increase of 2,858.06%. That is a compound annual growth rate of 12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 184.19B | -50.47% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | 132.58B | 8.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 52.46B |
| Siemens Healthineers AG | 47.59B |
| Bayer Aktiengesellschaft | 32.98B |
| Fresenius SE & Co. KGaA | 26.96B |
| Sartorius Aktiengesellschaft | 15.79B |
| Fresenius Medical Care AG | 11.50B |
| Carl Zeiss Meditec AG | 3.79B |
| Fielmann Group AG | 3.60B |